Kadcyla 100 mg, Pulver zur Herstellung eines Infusionslösungskonzentrates
7680628920015
CH-62892
Pulver zur Herstellung eines Infusionslösungskonzentrates
Associated product:
KADCYLA i.v. subst sèche 100 mg flac
1 / 3
google
Article details
- Package size
- 1
- Selling units
- 1
- Measure
- Durchstechflasche(n)
- Galenic form
- Pulver zur Herstellung eines Infusionslösungskonzentrates
- Galenic group
- unbekannt
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
PRC
|
100.0 MG | Substance | Wirkstoff (Principe actif) |
|
PRC
|
- | Substance | HNIDK |
|
PRC
|
- | Substance | HNIDK |
|
PRC
|
- | Substance | HNIDK |
|
PRC
|
1.29 MG | Substance | HBESI |
|
PRC
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 1642.70
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/01/2014
Authorization holder
Roche Pharma (Schweiz) AG
4058 Basel
Authorization information
- Swissmedic authorization number
- 62892
- Drug name
- Kadcyla, Pulver für ein Konzentrat zur Herstellung einer Infusionslösung
- Galenic form
- PULPI
- ATC Code
- L01FD03
- Authorization status
- Z
- Dispensing category
- A
- First authorization
- 02/05/2013
- Authorization expiration date
- 31/12/9999
- IT Number
- 07.16.1.
- Domain
- Human medicine
Package details
- Description (FR)
- KADCYLA i.v. subst sèche 100 mg flac
- Description (DE)
- KADCYLA i.v. Trockensub 100 mg Durchstf
- Market launch
- 02/05/2013
- Narcotic (BTM)
- No
Other package sizes (1)
KADCYLA i.v. subst sèche 160 mg flac
1 DUR
GTIN: 7680628920022